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BACKGROUND
Pancreas disease (PD) is caused by a single stranded RNA virus of the family •	 Togaviridae, genus Alphavirus known as 
the salmonid alphavirus.
PD is the most significant single infectious disease affecting marine salmon farming in Ireland and was first diagnosed •	
here in 1984.
PD was first reported in Scotland in 1976 and is now a significant economic disease for the salmon industries in Ireland, •	
Scotland and Norway.
The salmonid alphavirus also causes sleeping disease in rainbow trout and has been reported in France, UK, Germany, •	
Spain and Italy.
The disease has been reported to affect all age groups, although in Ireland it primarily affects salmon in their first year  •	
at sea.
To date the virus has only been isolated from salmonid fish.•	
CLINICAL SIGNS
Affected fish generally exhibit a sudden drop in feeding, become lethargic and anorexic. •	
Fish may cease shoaling and remain high in the water column. As a result they become prone to secondary infections, •	
parasites and water borne irritants.
Occasionally fish may be seen circling or spiralling in the water. Fish may also be observed spitting out feed pellets. •	
White/yellow casts are often observed in the water column and on the nets.
Internally signs of PD are variable and often there are no obvious internal abnormalities. •	
Fish may have no food in the gut and may have white or yellow intestinal casts. Occasionally there may be blood •	





Diagnosis of the disease has historically been based on histopathology.•	
Confirmatory testing includes virus isolation in cell culture, serological testing on blood serum and molecular methods.•	
Histopathologically, the disease is characterised by necrosis and fibrosis of the pancreatic acinar tissue as well as a •	
range of myopathies in the heart and skeletal muscle.
Molecular diagnostics have identified six sub-types of the salmonid alphavirus infecting farmed Atlantic salmon and •	
rainbow trout in both the marine and freshwater environments.
CONTROL
There are no treatments available to alleviate PD although dietary supplements may be of benefit.•	
A commercial vaccine is available, however research into the development of new vaccines is ongoing.•	
Regular screening of farmed stock should be used to identify early stages of infection. •	
Fallowing, stock selection and holding only single year class generations in any one bay may help in reducing the •	
occurrence and severity of the disease. 
The salmonid alphavirus is susceptible to extremes of pH and to temperatures > 60°C. A range of commonly used •	
disinfectants have been shown to be effective in inactivating the virus.
WHAT SHOULD I DO?
Minimise potentially stressful procedures such as handling, moving and grading when PD is suspected or confirmed.•	
As PD is not listed under Council Directive 2006/88/EC, control of the disease is a matter for the operator and the •	
retained veterinary practitioner.
Strict biosecurity measures should be implemented around the infected site.•	
Remove moribund and dead fish from infected pens/tanks daily. Mortalities should be disposed of in accordance with •	
current Animal By-Products Regulations.
If the vet notices a change in the nature of the infection and suspects a more virulent disease is emerging or •	
alternatively, if the disease is suspected in a new host species, you should contact the Fish Health Unit of the Marine 
Institute. If you suspect the presence of a listed disease you should also notify the Marine Institute.
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